Amy DuRoss

President, Cell and Gene Therapy • CSafe

Amy DuRoss leads CSafe’s CGT solutions portfolio to support intelligent transport of high-value personalized therapies and vaccines to meet the unprecedented global supply chain transport complexity of CGT products.

Ms. DuRoss brings more than 25 years’ experience to her new position. Prior to joining CSafe, she was the co-founder and CEO of Vineti, an enterprise software platform used to digitize chain of identity and chain of custody requirements for CGT products.
Ms. DuRoss earned her bachelor’s and two master’s degrees, including her MBA, from Stanford University. She serves on the boards of Biolife Solutions (BLFS), MJH, Americans for Cures, and the ARM Foundation and is a member of the Aspen Institute Global Network.

Also Speaking

Marc Wolfgang

Vice President of Technical Development • BioNTech

Kimberly Goodspeed

Assistant Professor • University of Texas Southwestern Medical Center

John Balchunas

Workforce Director • The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

Also Speaking


Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.


Find out more and apply to get involved at the briefings taking place at Advanced Therapies Week.